Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer.

Jansson S, Bendahl PO, Grabau DA, Falck AK, Fernö M, Aaltonen K, Rydén L.

PLoS One. 2014 Jul 15;9(7):e102176. doi: 10.1371/journal.pone.0102176. eCollection 2014.

PMID:
25025175
[PubMed - in process]
Free PMC Article
2.

Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.

Chinchar E, Makey KL, Gibson J, Chen F, Cole SA, Megason GC, Vijayakumar S, Miele L, Gu JW.

Vasc Cell. 2014 Jun 1;6:12. doi: 10.1186/2045-824X-6-12. eCollection 2014.

PMID:
24914410
[PubMed]
Free PMC Article
3.

Antiangiogenic therapy using sunitinib combined with rapamycin retards tumor growth but promotes metastasis.

Yin T, He S, Ye T, Shen G, Wan Y, Wang Y.

Transl Oncol. 2014 Apr;7(2):221-9. doi: 10.1016/j.tranon.2014.02.007. Epub 2014 Mar 4.

PMID:
24742865
[PubMed]
Free PMC Article
4.

Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study.

Bachelot T, Garcia-Saenz JA, Verma S, Gutierrez M, Pivot X, Kozloff MF, Prady C, Huang X, Khosravan R, Wang Z, Cesari R, Tassell V, Kern KA, Blay JY, Lluch A.

BMC Cancer. 2014 Mar 7;14:166. doi: 10.1186/1471-2407-14-166.

PMID:
24606768
[PubMed - in process]
Free PMC Article
5.

Prediction of cancer drugs by chemical-chemical interactions.

Lu J, Huang G, Li HP, Feng KY, Chen L, Zheng MY, Cai YD.

PLoS One. 2014 Feb 3;9(2):e87791. doi: 10.1371/journal.pone.0087791. eCollection 2014.

PMID:
24498372
[PubMed - in process]
Free PMC Article
6.

Antiangiogenesis therapy for breast cancer: an update and perspectives from clinical trials.

Fakhrejahani E, Toi M.

Jpn J Clin Oncol. 2014 Mar;44(3):197-207. doi: 10.1093/jjco/hyt201. Epub 2014 Jan 27. Review.

PMID:
24474817
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

MicroRNAs and triple negative breast cancer.

D'Ippolito E, Iorio MV.

Int J Mol Sci. 2013 Nov 11;14(11):22202-20. doi: 10.3390/ijms141122202. Review.

PMID:
24284394
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Blood-based biomarkers for the optimization of anti-angiogenic therapies.

Rabascio C, Bertolini F.

Cancers (Basel). 2010 May 28;2(2):1027-39. doi: 10.3390/cancers2021027.

PMID:
24281105
[PubMed]
Free PMC Article
9.

Novel combinations for the treatment of metastatic breast cancer.

Vahdat LT.

Cancers (Basel). 2010 Jan 14;2(1):1-19. doi: 10.3390/cancers2010001.

PMID:
24281029
[PubMed]
Free PMC Article
10.

Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy.

Lindner R, Sullivan C, Offor O, Lezon-Geyda K, Halligan K, Fischbach N, Shah M, Bossuyt V, Schulz V, Tuck DP, Harris LN.

PLoS One. 2013 Nov 18;8(11):e71915. doi: 10.1371/journal.pone.0071915. eCollection 2013.

PMID:
24260093
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes.

Lehmann BD, Pietenpol JA.

J Pathol. 2014 Jan;232(2):142-50. doi: 10.1002/path.4280. Review.

PMID:
24114677
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Newer therapies for the treatment of metastatic breast cancer: a clinical update.

Mohan A, Ponnusankar S.

Indian J Pharm Sci. 2013 May;75(3):251-61. doi: 10.4103/0250-474X.117396. Review.

PMID:
24082340
[PubMed]
Free PMC Article
13.

Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies--results of a phase I dose-escalation study.

Blais N, Camidge DR, Jonker DJ, Soulières D, Laurie SA, Diab SG, Ruiz-Garcia A, Thall A, Zhang K, Chao RC, Chow LQ.

Invest New Drugs. 2013 Dec;31(6):1487-98. doi: 10.1007/s10637-013-0010-4. Epub 2013 Aug 22.

PMID:
23963796
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells.

Tsai CH, Yang CW, Wang JY, Tsai YF, Tseng LM, King KL, Chen WS, Chiu JH, Shyr YM.

Evid Based Complement Alternat Med. 2013;2013:421051. doi: 10.1155/2013/421051. Epub 2013 Jun 25.

PMID:
23878598
[PubMed]
Free PMC Article
15.

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial.

Baselga J, Costa F, Gomez H, Hudis CA, Rapoport B, Roche H, Schwartzberg LS, Petrenciuc O, Shan M, Gradishar WJ.

Trials. 2013 Jul 22;14:228. doi: 10.1186/1745-6215-14-228.

PMID:
23876062
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis.

Shao R.

Front Physiol. 2013 May 28;4:122. doi: 10.3389/fphys.2013.00122. eCollection 2013.

PMID:
23755018
[PubMed]
Free PMC Article
17.

The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors.

Rosen LS, Lipton L, Price TJ, Belman ND, Boccia RV, Hurwitz HI, Stephenson JJ Jr, Wirth LJ, McCoy S, Hei YJ, Hsu CP, Tebbutt NC.

BMC Cancer. 2013 May 16;13:242. doi: 10.1186/1471-2407-13-242.

PMID:
23679351
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer.

Boku N, Muro K, Machida N, Hashigaki S, Kimura N, Suzuki M, Lechuga M, Miyata Y.

Invest New Drugs. 2014 Apr;32(2):261-70. doi: 10.1007/s10637-013-9948-5. Epub 2013 May 12.

PMID:
23665950
[PubMed - in process]
Free PMC Article
19.

A review on angiogenesis and its assays.

Tahergorabi Z, Khazaei M.

Iran J Basic Med Sci. 2012 Nov;15(6):1110-26.

PMID:
23653839
[PubMed]
Free PMC Article
20.

Biomarkers for anti-angiogenic therapy in cancer.

Wehland M, Bauer J, Magnusson NE, Infanger M, Grimm D.

Int J Mol Sci. 2013 Apr 29;14(5):9338-64. doi: 10.3390/ijms14059338.

PMID:
23629668
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk